UT Southwestern – Cutting-edge Discoveries, Transforming Patient Care

The American Cancer Society estimates that in 2014, 63,920 people were diagnosed with kidney cancer and 13,860 people died from the disease. At UT Southwestern Harold C. Simmons Comprehensive Cancer Center, we are committed to the development of new therapies and the search for a cure.

In 2013, UT Southwestern formalized its commitment to the care of kidney cancer patients and research on kidney cancer by officially instituting a Kidney Cancer Program (KCP). The KCP includes more than 20 physicians, many of whom are renowned international leaders in their fields of urology, pediatric oncology, adult oncology, radiation oncology, radiology, and pathology. In addition, more than 40 scientists with their research laboratories are a part of the KCP.

The KCP builds on landmark discoveries made by scientists at UT Southwestern over the last three decades. Drs. Steven McKnight and David Russell discovered HIF-2α, a protein that mediates kidney cancer development. Subsequent studies by Drs. Richard Bruick and Kevin Gardnerled to the development of a drug that blocks HIF-2 activity. In addition, DJ Pan, Ph.D., discovered that the TSC1/TSC2 complex regulates TOR, which is the target of two kidney cancer drugs. Years later, James Brugarolas, M.D., Ph.D., discovered mutations in TSC1 in kidney cancer, and the presence of these mutations may identify patients most likely to respond to TOR inhibitors. Finally, recent discoveries by several investigators at UT Southwestern, including Payal Kapur, M.D., determined that there are different subtypes of kidney cancer with different biology and outcomes.

Source: https://www.utsouthwestern.edu/research/kidney-cancer/index.html

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Chuck Stravin: “With Time Comes Hope”

Chuck Stravin: “With Time Comes Hope”

Chuck Stravin is married to his high school sweetheart, Liz, and lives in Quincy, Massachusetts, just south of Boston. Diagnosed with advanced renal cancer in 2015, Chuck is beating the odds and has become a passionate advocate for kidney cancer research funding.   For this month's Community...

SPRING ADVOCACY DAYS 2023 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

From the Heart to the Hill: Advocating for Kidney Cancer Research Funding

From the Heart to the Hill: Advocating for Kidney Cancer Research Funding

Spring Advocacy : By the Numbers KidneyCAN is thrilled to announce the success of our Spring Advocacy Days event, which took place on March 13th in person in Washington, D.C., and on March 14th virtually. We are grateful for the 186 confirmed meetings with representatives from 42 states, including...

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING YOUR CARE TEAM

TREATMENT & TRIAL OPTIONS

LIVING WELL WITH KIDNEY CANCER

CLINICAL TRIALS →

IMMUNOTHERAPY →

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

From the Heart to the Hill: Advocating for Kidney Cancer Research Funding

From the Heart to the Hill: Advocating for Kidney Cancer Research Funding

Spring Advocacy : By the Numbers KidneyCAN is thrilled to announce the success of our Spring Advocacy Days event, which took place on March 13th in person in Washington, D.C., and on March 14th virtually. We are grateful for the 186 confirmed meetings with representatives from 42 states, including...

SUPPORT OUR WORK →

ROCK THE RUN 2023 →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Chuck Stravin: “With Time Comes Hope”

Chuck Stravin: “With Time Comes Hope”

Chuck Stravin is married to his high school sweetheart, Liz, and lives in Quincy, Massachusetts, just south of Boston. Diagnosed with advanced renal cancer in 2015, Chuck is beating the odds and has become a passionate advocate for kidney cancer research funding.   For this month's Community...